» Articles » PMID: 20360868

Estimating the Disease Burden of Pandemic (H1N1) 2009 Virus Infection in Hunter New England, Northern New South Wales, Australia, 2009

Overview
Journal PLoS One
Date 2010 Apr 3
PMID 20360868
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: On May 26, 2009, the first confirmed case of Pandemic (H1N1) 2009 virus (pH1N1) infection in Hunter New England (HNE), New South Wales (NSW), Australia (population 866,000) was identified. We used local surveillance data to estimate pH1N1-associated disease burden during the first wave of pH1N1 circulation in HNE.

Methods: Surveillance was established during June 1-August 30, 2009, for: 1) laboratory detection of pH1N1 at HNE and NSW laboratories, 2) pH1N1 community influenza-like illness (ILI) using an internet survey of HNE residents, and 3) pH1N1-associated hospitalizations and deaths using respiratory illness International Classification of Diseases 10 codes at 35 HNE hospitals and mandatory reporting of confirmed pH1N1-associated hospitalizations and deaths to the public health service. The proportion of pH1N1 positive specimens was applied to estimates of ILI, hospitalizations, and deaths to estimate disease burden.

Results: Of 34,177 specimens tested at NSW laboratories, 4,094 (12%) were pH1N1 positive. Of 1,881 specimens from patients evaluated in emergency departments and/or hospitalized, 524 (26%) were pH1N1 positive. The estimated number of persons with pH1N1-associated ILI in the HNE region was 53,383 (range 37,828-70,597) suggesting a 6.2% attack rate (range 4.4-8.2%). An estimated 509 pH1N1-associated hospitalizations (range 388-630) occurred (reported: 184), and up to 10 pH1N1-associated deaths (range 8-13) occurred (reported: 5). The estimated case hospitalization ratio was 1% and case fatality ratio was 0.02%.

Discussion: The first wave of pH1N1 activity in HNE resulted in symptomatic infection in a small proportion of the population, and the number of HNE pH1N1-associated hospitalizations and deaths is likely higher than officially reported.

Citing Articles

Utility of state-level influenza disease burden and severity estimates to investigate an apparent increase in reported severe cases of influenza A(H1N1) pdm09 - Arizona, 2015-2016.

Russell K, Herrick K, Venkat H, Brady S, Komatsu K, Goodin K Epidemiol Infect. 2018; 146(11):1359-1365.

PMID: 29898797 PMC: 9133685. DOI: 10.1017/S0950268818001516.


Enablers of innovation in digital public health surveillance: lessons from Flutracking.

Dalton C Int Health. 2017; 9(3):145-147.

PMID: 28582555 PMC: 5881271. DOI: 10.1093/inthealth/ihx009.


Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A Virus.

Carbone V, Schneider E, Rockman S, Baker M, Huang J, Ong C Molecules. 2015; 20(6):10415-34.

PMID: 26056814 PMC: 6272818. DOI: 10.3390/molecules200610415.


Hospitalization risk of the 2009 H1N1 pandemic cases in Hong Kong.

Wang X, Wong C, Chan K, Chan K, Cao P, Peiris J BMC Infect Dis. 2014; 14:32.

PMID: 24428855 PMC: 3898487. DOI: 10.1186/1471-2334-14-32.


Case fatality risk of influenza A (H1N1pdm09): a systematic review.

Wong J, Kelly H, Ip D, Wu J, Leung G, Cowling B Epidemiology. 2013; 24(6):830-41.

PMID: 24045719 PMC: 3809029. DOI: 10.1097/EDE.0b013e3182a67448.


References
1.
Fox J, COONEY M, Hall C, Foy H . Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol. 1982; 116(2):228-42. DOI: 10.1093/oxfordjournals.aje.a113408. View

2.
Mullooly J, Bridges C, Thompson W, Chen J, Weintraub E, Jackson L . Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2006; 25(5):846-55. DOI: 10.1016/j.vaccine.2006.09.041. View

3.
Parrella A, Dalton C, Pearce R, Litt J, Stocks N . ASPREN surveillance system for influenza-like illness - A comparison with FluTracking and the National Notifiable Diseases Surveillance System. Aust Fam Physician. 2009; 38(11):932-6. View

4.
Mathews J, Chesson J, McCaw J, McVernon J . Understanding influenza transmission, immunity and pandemic threats. Influenza Other Respir Viruses. 2009; 3(4):143-9. PMC: 4634682. DOI: 10.1111/j.1750-2659.2009.00089.x. View

5.
Wilson N, Baker M . The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill. 2009; 14(26). View